Regencell Bioscience Holdings Limited
RGC
Rank in Stocks
#3353
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Share Price
$10.57
Market Cap
$5.24B
Change (1 day)
5.20%
Change (1 year)
-37.66%
Country
HK
Trade Regencell Bioscience Holdings Limited (RGC)
Category
Healthcare
Number of shares outstanding for Regencell Bioscience Holdings Limited (RGC)
Number of shares outstanding as of June 2026: 494.70M
According to Regencell Bioscience Holdings Limited latest financial reports and stock price the company's current number of shares outstanding is 494.70M. At the end of June 2024 the company had 494.49M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Regencell Bioscience Holdings Limited (RGC) from 2019 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 494.70M | 0.04% |
| 2025 | 494.49M | 0.00% |
| 2024 | 494.49M | 0.00% |
| 2023 | 494.49M | 0.00% |
| 2022 | 494.49M | 2.93% |
| 2021 | 480.40M | 0.00% |
| 2020 | 480.40M | 0.00% |
| 2019 | 480.40M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 385.01% |
IN
|
